Chimeric Switch Receptor: Switching for Improved Adoptive T-Cell Therapy Against Cancers
Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor-modified effector cells
Beta-2 Microglobulin Knockout K562 Cell-Based Artificial Antigen Presenting Cells For Ex Vivo Expansion of T Lymphocytes
